|
🐜
|
Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant
46 auth.
Xianding Deng,
M. Garcia-Knight,
M. Khalid,
V. Servellita,
Candace Wang,
M. Morris,
A. Sotomayor-González,
Dustin R. Glasner,
Kevin R. Reyes,
A. Gliwa,
N. P. Reddy,
Claudia Sanchez San Martin,
S. Federman,
Jing Cheng,
J. Balcerek,
...
Jordan Taylor,
J. Streithorst,
Steve Miller,
B. Sreekumar,
Pei-Yi Chen,
U. Schulze-Gahmen,
T. Y. Taha,
J. Hayashi,
C. Simoneau,
G. R. Kumar,
Sarah McMahon,
Peter V. Lidsky,
Yinghong Xiao,
P. Hemarajata,
N. Green,
A. Espinosa,
Chantha Kath,
M. Haw,
J. Bell,
J. Hacker,
C. Hanson,
D. Wadford,
C. Anaya,
D. Ferguson,
Phillip A. Frankino,
H. Shivram,
L. Lareau,
S. Wyman,
M. Ott,
R. Andino,
C. Chiu
|
8 |
2021 |
8
🐜
|
|
🐜
|
Photochemical inactivation of viruses and bacteria in platelet concentrates by use of a novel psoralen and long‐wavelength ultraviolet light
24 auth.
Lily Lin,
David Cook,
G. Wiesehahn,
R. Alfonso,
B. Behrman,
G. Cimino,
L. Corten,
P. Damonte,
R. Dikeman,
K. Dupuis,
...
Y. Fang,
C. Hanson,
J. Hearst,
C. Y. Lin,
H. Londe,
K. Metchette,
A. Nerio,
J. Pu,
A. Reames,
M. Rheinschmidt,
J. Tessman,
S. Isaacs,
S. Wollowitz,
L. Corash
|
8 |
1997 |
8
🐜
|
|
🐜
|
Transmission, infectivity, and antibody neutralization of an emerging SARS-CoV-2 variant in California carrying a L452R spike protein mutation
46 auth.
Xianding Deng,
M. Garcia-Knight,
M. Khalid,
V. Servellita,
Candace Wang,
M. Morris,
A. Sotomayor-González,
Dustin R. Glasner,
Kevin R. Reyes,
A. Gliwa,
N. P. Reddy,
Claudia Sanchez San Martin,
S. Federman,
Jing Cheng,
J. Balcerek,
...
Jordan Taylor,
J. Streithorst,
Steve Miller,
G. R. Kumar,
B. Sreekumar,
Pei-Yi Chen,
U. Schulze-Gahmen,
T. Y. Taha,
J. Hayashi,
C. Simoneau,
Sarah McMahon,
Peter V. Lidsky,
Yinghong Xiao,
P. Hemarajata,
N. Green,
A. Espinosa,
Chantha Kath,
M. Haw,
J. Bell,
J. Hacker,
C. Hanson,
D. Wadford,
C. Anaya,
D. Ferguson,
L. Lareau,
Phillip A. Frankino,
H. Shivram,
S. Wyman,
M. Ott,
R. Andino,
C. Chiu
|
7 |
2021 |
7
🐜
|
|
🐜
|
Inactivation of viruses in platelet concentrates by photochemical treatment with amotosalen and long‐wavelength ultraviolet light
8 auth.
Lily Lin,
C. Hanson,
H. Alter,
V. Jauvin,
K. Bernard,
K. Murthy,
...
P. Metzel,
L. Corash
|
7 |
2005 |
7
🐜
|
|
🐜
|
Production of site-selected neutralizing human monoclonal antibodies against the third variable domain of the human immunodeficiency virus type 1 envelope glycoprotein.
8 auth.
M. Gorny,
J. Y. Xu,
V. Gianakakos,
S. Karwowska,
C. Williams,
H. Sheppard,
...
C. Hanson,
S. Zolla-Pazner
|
7 |
1991 |
7
🐜
|
|
🐜
|
Inactivated simian immunodeficiency virus vaccine failed to protect rhesus macaques from intravenous or genital mucosal infection but delayed disease in intravenously exposed animals
9 auth.
S. Sutjipto,
N. Pedersen,
C. Miller,
M. Gardner,
C. Hanson,
A. Gettie,
...
M. Jennings,
J. Higgins,
P. Marx
|
6 |
1990 |
6
🐜
|
|
🐜
|
Crosslinked HIV-1 envelope–CD4 receptor complexes elicit broadly cross-reactive neutralizing antibodies in rhesus macaques
8 auth.
T. Fouts,
Karla Godfrey,
K. Bobb,
D. Montefiori,
C. Hanson,
V. Kalyanaraman,
...
A. Devico,
R. Pal
|
6 |
2002 |
6
🐜
|
|
🦁
|
Photochemical inactivation of DNA and RNA viruses by psoralen derivatives.
C. Hanson,
J. Riggs,
E. H. Lennette
|
6 |
1978 |
6
🦁
|
|
🐢
|
Neutralizing antibody responses to autologous and heterologous isolates of human immunodeficiency virus.
T. Wrin,
L. Crawford,
L. Sawyer,
P. Weber,
H. Sheppard,
C. Hanson
|
6 |
1994 |
6
🐢
|
|
🐜
|
Quantification of antibody avidities and accurate detection of SARS-CoV-2 antibodies in serum and saliva on plasmonic substrates
19 auth.
Tiancheng Liu,
J. Hsiung,
Su Zhao,
J. Kost,
D. Sreedhar,
C. Hanson,
Kjerstie Olson,
D. Keare,
Shin Ting Chang,
K. Bliden,
...
P. Gurbel,
U. Tantry,
John Roche,
C. Press,
J. Boggs,
Jorge P. Rodriguez-Soto,
J. Montoya,
M. Tang,
Hongjie Dai
|
6 |
2020 |
6
🐜
|
